Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA)

BACKGROUND: Trastuzumab is successfully used for the treatment of HER2-positive breast cancer. Because of its association with cardiotoxicity, LVEF is monitored by MUGA, though this is a relatively late measure of cardiac function. Diastolic dysfunction (DD) is believed to be an early predictor of c...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Nucl Cardiol
Hlavní autoři: Reuvekamp, E. J., Bulten, B. F., Nieuwenhuis, A. A., Meekes, M. R. A., de Haan, A. F. J., Tol, J., Maas, A. H. E. M., Elias-Smale, S. E., de Geus-Oei, L. F.
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer US 2015
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4956716/
https://ncbi.nlm.nih.gov/pubmed/26048264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12350-015-0164-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky